MapLight Therapeutics MPLT
NASDAQ MPLT
$7.56 +0.28 (+3.85%)
As of: Nov 10, 2026 · 3:00 PM EST

MapLight Therapeutics (MPLT) Share-based Compensation (2024 - 2026)

Updated

MapLight Therapeutics (MPLT) reported Share-based Compensation of $8.63 million for Q2 2026, compared with $148,000 a year earlier.

Analysis

MapLight Therapeutics (MPLT) Share-based Compensation (2024 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, MapLight Therapeutics' Share-based Compensation came in at $44.42 million; for FY2025, it came in at $36.01 million.

  • By year, Share-based Compensation came in at $1.08 million in FY2024.
  • Five-year quarterly Share-based Compensation spans a low of $125,000 in Q3 2025 and a high of $35.52 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn 200.00 Mn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 357.00 Mn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 160.00 Mn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 369.00 Mn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn -
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn -
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn 128.00 Mn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 234.00 Mn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn 362.00 Mn
10 MapLight Therapeutics 340.28 Mn 340.28 Mn - 8.63 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 8.63 Mn
Dec 31, 2025 35.52 Mn
Sep 30, 2025 125,000.00
Jun 30, 2025 148,000.00
Dec 31, 2024 214,000.00
Sep 30, 2024 354,000.00
API Access

MapLight Therapeutics Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=MPLT&period=max&api_key=YOUR_API_KEY